Medical Devices

Parkinson’s disease clinical trials: Challenges, advancements, and the role of technology

09-Jan-2019 By Melissa Fassbender

For research in areas such as Parkinson’s disease, digital endpoints may soon be used as primary endpoints, allowing for in-home clinical trials to be conducted over longer periods of time, says CRO.

Apptomics aims to establish its digital platform as the standard for monitoring movement disorders

08-Jan-2019 By Melissa Fassbender

Apptomics is working with BBK and Biotaware to develop the remote health-monitoring platform, which recently served as a digital biomarker to evaluate treatment effects as part of an essential tremor clinical trial.

Digital tech exploded in 2018: Will 2019 see broad adoption?

04-Jan-2019 By Melissa Fassbender

Awareness around the potential opportunities created by artificial intelligence has never been higher, but pharma’s biggest challenge in 2019 will be adopting and scaling the right technology to improve patient outcomes, says an industry executive.

2018 regulatory round-up: Patient safety, data transparency, innovative trial designs

18-Dec-2018 By Melissa Fassbender

Global regulatory agencies had a busy 2018. Here, we take a look back at some of the key developments throughout the year, as the industry navigated challenging politics, pressure to increase transparency, and the rapidly evolving digital health space.

Histopathology providers merge to serve biopharma, CRO industry as single company backed by PE

12-Dec-2018 By Melissa Fassbender

Histo-Scientific Research Laboratories and Vet Path Services have merged to create one company dedicated to providing histology, pathology, and archiving services to the biopharmaceutical, medical device, and contract research industries.

FDA’s MyStudies release is a ‘major milestone’ with ‘profound’ implications, says Iqvia

04-Dec-2018 By Melissa Fassbender

The FDA recently released open source code and technical documents for its new mobile app – MyStudies – which is designed to collect information about medication use, health system touchpoints, and patient-reported outcomes.

The top 15 wearables for incorporating real-world data into clinical trials

04-Dec-2018 By Melissa Fassbender

Litmus Health’s profile of the wearables market names the top 15 devices today available to researchers incorporating real-life data into studies and trials – with a focus on data quality and transparency.

AAPS PharmSci 360 preview: ‘Small-conference feel and big-conference breadth’

30-Oct-2018 By Melissa Fassbender

AAPS PharmSci 360 is a new conference this year, created in response to a desire for “fresh science,” specifically with chemical and biomolecular components. So what can you expect?

‘The opportunities for AI to revolutionize the pharmaceutical industry are clear’: Report

11-Oct-2018 By Melissa Fassbender

Researchers are using artificial intelligence to catalyze drug discovery and preclinical drug development - improving predictive models to guide efficient design and optimizing multi-drug regimens, as two recent examples.

At the source

The top 3 myths of ‘going digital’ (and the realities)

12-Sep-2018 By Melissa Fassbender

The top three myths of ‘going digital’ relate to the industry’s self-image, the perceived role of technology, and current market conditions – still, digital is not a fad and is here to stay, says industry expert.

People on the Move: Outsourcing-Pharma roundup August '18

07-Sep-2018 By Melissa Fassbender

This month marked the effective start date for Parexel's new executive VP and CFO Greg Rush, who joins August's People on the Move with several other c-suite hires, including a new CEO at Citoxlab and COO at ProSciento.

Robotics, automation to play a ‘fundamental role’ in Icon’s continued success: Q2 earnings call

08-Aug-2018 By Melissa Fassbender

Robotics and automation will help improve the clunky and expensive clinical trial process, says Icon CEO – as the company continues to evaluate potential opportunities to improve efficiency.

State of the Industry: What readers have to say

08-Aug-2018 By Melissa Fassbender

Outsourcing-Pharma recently conducted a second ‘state of the industry’ survey to gauge views about the current state of the global pharmaceutical outsourcing market and the evolving relationships of those involved.

Life science advances and gender equity on the program for DIA 2018

19-Jun-2018 By Melissa Fassbender

This year’s DIA Global Annual Meeting will focus on the latest global trends and showcase the "diverse group of key individuals driving the life science ecosystem forward," says DIA Americas managing director.

State of the Industry

State of the Industry: Taking the pulse of the contract services market

11-Jun-2018 By Melissa Fassbender

Following on from the success of last year's survey, Outsourcing-Pharma is running another 'state of the industry' survey to gauge views about the current state of the pharmaceutical contract services industry.